MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

INTERPACE BIOSCIENCES, INC. (IDXG)

INTERPACE BIOSCIENCES, INC. (IDXG)

|||

Balance Sheets Overview

Current Ratio
221.53%
Quick Ratio
221.53%
Cash Ratio
54.29%
Debt to Asset Ratio
32.72%
Unit: Thousand (K) dollars
Assets Breakdown
    • Deferred tax asset
    • Accounts receivable
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Other long-term liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
2,688
2,647
2,505
1,423
Accounts receivable
6,311
5,925
5,649
5,966
Other current assets
1,969
1,391
1,746
1,741
Total current assets
10,968
9,963
9,900
9,130
Property and equipment, net
1,621
1,315
1,423
1,541
Operating lease right of use assets
1,001
1,110
1,217
1,320
Deferred tax asset
20,915
20,977
21,254
-
Other long-term assets
44
44
44
45
Total assets
34,549
33,409
33,838
12,036
Accounts payable
1,555
805
983
1,411
Accrued salary and bonus
952
714
1,886
1,447
Other accrued expenses
1,784
1,783
1,574
1,450
Note payable at fair value
-
-
-
977
Current liabilities of discontinued operations
660
660
660
660
Total current liabilities
4,951
3,962
5,103
5,945
Operating lease liabilities, net of current portion
516
635
752
864
Other long-term liabilities
5,838
5,730
5,620
5,525
Total liabilities
11,305
10,327
11,475
12,334
Common stock, .01 par value 100,000,000 shares authorized 27,844,994 and 4,569,333 shares issued, respectively 27,700,904 and 4,428,539 shares outstanding, respectively
640
640
407
407
Additional paid-in capital
234,608
234,604
234,833
234,829
Accumulated deficit
-209,926
-210,084
-210,805
-233,462
Treasury stock, at cost (144,090 and 140,794 shares, respectively)
2,078
2,078
2,072
2,072
Total stockholders equity
23,244
23,082
22,363
-298
Total liabilities and stockholders equity
34,549
33,409
33,838
12,036
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable$6,311K (-12.72%↓ Y/Y)Cash and cashequivalents$2,688K (435.46%↑ Y/Y)Other current assets$1,969K (11.18%↑ Y/Y)Deferred tax asset$20,915K Total current assets$10,968K (15.40%↑ Y/Y)Property and equipment,net$1,621K (18.67%↑ Y/Y)Operating lease right ofuse assets$1,001K (-29.51%↓ Y/Y)Other long-termassets$44K (-2.22%↓ Y/Y)Total assets$34,549K (180.09%↑ Y/Y)Total liabilities andstockholders equity$34,549K (180.09%↑ Y/Y)Total stockholdersequity$23,244K (2016.24%↑ Y/Y)Total liabilities$11,305K (-16.56%↓ Y/Y)Accumulated deficit-$209,926K (10.43%↑ Y/Y)Treasury stock, at cost(144,090 and 140,794...$2,078K (0.43%↑ Y/Y)Additional paid-in capital$234,608K (-0.09%↓ Y/Y)Other long-termliabilities$5,838K (7.61%↑ Y/Y)Total currentliabilities$4,951K (-30.75%↓ Y/Y)Operating leaseliabilities, net of current...$516K (-47.02%↓ Y/Y)Common stock, .01 parvalue 100,000,000...$640K (57.25%↑ Y/Y)Other accruedexpenses$1,784K (25.46%↑ Y/Y)Accounts payable$1,555K (24.40%↑ Y/Y)Accrued salary and bonus$952K (-53.45%↓ Y/Y)Current liabilities ofdiscontinued operations$660K (0.00%↑ Y/Y)